Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2

Inhibition of the protein kinase CSNK2 with any of 30 specific and selective inhibitors representing different chemotypes, blocked replication of pathogenic human and murine β-coronaviruses. The potency of in-cell CSNK2A target engagement across the set of inhibitors correlated with antiviral activity and genetic knockdown confirmed the essential role of the CSNK2 holoenzyme in β-coronavirus replication. Spike protein uptake was blocked by CSNK2A inhibition, indicating that antiviral activity was due in part to a suppression of viral entry. CSNK2A inhibition may be a viable target for development of new broad spectrum anti-β-coronavirus drugs. GRAPHICAL ABSTRACT

[1]  L. Pinna,et al.  Targeting CK2 in cancer: a valuable strategy or a waste of time? , 2021, Cell death discovery.

[2]  C. Asquith,et al.  Evaluation and identification of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV). , 2021, Bioorganic & medicinal chemistry letters.

[3]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[4]  M. Diamond,et al.  Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell , 2021, Cell Reports.

[5]  Matthew J. O’Meara,et al.  Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 , 2021, Science.

[6]  Ana Martínez,et al.  Kinase Inhibitors as Underexplored Antiviral Agents , 2021, Journal of medicinal chemistry.

[7]  M. Schapira,et al.  The Promise and Peril of Chemical Probe Negative Controls. , 2021, ACS chemical biology.

[8]  P. McPherson,et al.  SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis , 2021, Journal of Biological Chemistry.

[9]  S. Knapp,et al.  Development of a potent and selective chemical probe for the pleiotropic kinase CK2. , 2020, Cell chemical biology.

[10]  Lisa E. Gralinski,et al.  SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo , 2020, Science.

[11]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[12]  Miguel Correa Marrero,et al.  Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms , 2020, Science.

[13]  V. Chitalia,et al.  A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals , 2020, Journal of Translational Medicine.

[14]  W. Zuercher,et al.  Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines. , 2020, Bioorganic & medicinal chemistry letters.

[15]  E. Mahabir,et al.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2 , 2020, Viruses.

[16]  P. Vidalain,et al.  The current landscape of coronavirus-host protein–protein interactions , 2020, Journal of Translational Medicine.

[17]  R. Baric,et al.  Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice , 2020, Cell Reports.

[18]  Andrew R. Leach,et al.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.

[19]  Lisa E. Gralinski,et al.  SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract , 2020, Cell.

[20]  Shalini Sharma,et al.  Host-Directed Antiviral Therapy , 2020, Clinical Microbiology Reviews.

[21]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[22]  T. Jodlowski,et al.  Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[23]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[24]  R. Baric,et al.  Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry , 2020, PLoS pathogens.

[25]  T. Willson,et al.  SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K. , 2019, ACS medicinal chemistry letters.

[26]  T. Willson,et al.  The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification , 2019, bioRxiv.

[27]  S. Knapp,et al.  Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity. , 2019, Journal of medicinal chemistry.

[28]  M. Salvi,et al.  Activity of CK2α protein kinase is required for efficient replication of some HPV types , 2019, PLoS pathogens.

[29]  Stephen J. Capuzzi,et al.  SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK) , 2018, bioRxiv.

[30]  T. Willson,et al.  Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement , 2017, Cell chemical biology.

[31]  Lisa E. Gralinski,et al.  Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.

[32]  J. Dye,et al.  Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects , 2017, The Journal of clinical investigation.

[33]  Lyn H. Jones,et al.  Applications of chemogenomic library screening in drug discovery , 2017, Nature Reviews Drug Discovery.

[34]  Fang Li,et al.  Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.

[35]  D. Litchfield,et al.  Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells , 2016, Clinical Cancer Research.

[36]  J. Jensen,et al.  Antiviral drug resistance as an adaptive process , 2016, Virus evolution.

[37]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[38]  L. Pelkmans,et al.  Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner , 2014, PLoS pathogens.

[39]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[40]  Brock F. Binkowski,et al.  Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.

[41]  R. Striker,et al.  Phosphorylation events during viral infections provide potential therapeutic targets , 2011, Reviews in medical virology.

[42]  D. Litchfield,et al.  Protein Kinase CK2 in Health and Disease , 2009, Cellular and Molecular Life Sciences.

[43]  Scott H Randell,et al.  Well-differentiated human airway epithelial cell cultures. , 2005, Methods in molecular medicine.

[44]  L. Pinna,et al.  One‐thousand‐and‐one substrates of protein kinase CK2? , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  D. Litchfield.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.

[46]  R. Baric,et al.  Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59 , 2002, Journal of Virology.

[47]  E. Krebs,et al.  Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. , 1992, The Journal of biological chemistry.

[48]  E. Krebs,et al.  Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Identification of the autophosphorylation site and a site phosphorylated by p34cdc2. , 1991, The Journal of biological chemistry.